Tumor neoepitope selection for biomarker discovery and therapeutic vaccination

  • Jeff Hammerbacher
  • A Genomics@JHU Seminar
  • When: October 24, 2016, 13:30
  • Where: The Barber Conference Room at Charles Commons
    10 E 33rd Street
    Baltimore, MD 21218
  • Light refreshments served at 1:00 PM

Abstract

jeff-hammerbacherWe’ll review some open source software our lab has developed to facilitate a Phase I clinical trial of a personalized therapeutic vaccine targeting tumor neoepitopes. We’ll also present some results from our analysis of clinical trials of checkpoint blockade in 3 different cancer types and some open source software we’ve created to facilitate similar analyses.

Biography

Jeff Hammerbacher

Founder and Chief Scientist of Cloudera, Assistant Professor at the Icahn School of Medicine at Mount Sinai, and Director at Sage Bionetworks. Formerly an EntrepJreneur in Residence at Accel Partners. Before Accel, conceived, built, and led the Data team at Facebook. Before Facebook, quantitative analyst on Wall Street. Earned a Bachelor’s Degree in Mathematics from Harvard University.

Genomics @ JHU Seminar Series

View All Events